background
role
human
bocaviru
hbov
respiratori
ill
uncertain
hbov
genom
dna
frequent
detect
ill
healthi
children
hypothes
splice
viral
capsid
messeng
rna
mrna
produc
activ
replic
might
better
marker
acut
infect
method
part
etiolog
pneumonia
commun
epic
studi
children
age
year
hospit
communityacquir
pneumonia
cap
children
asymptomat
time
elect
outpati
surgeri
control
enrol
nasopharyngealoropharyng
specimen
test
hbov
mrna
genom
dna
quantit
polymeras
chain
reaction
result
hbov
dna
detect
patient
cap
control
odd
ratio
confid
interv
ci
hbov
mrna
detect
respect
ci
adjust
age
enrol
month
detect
respiratori
virus
hbov
mrna
detect
adjust
ci
dna
adjust
ci
associ
cap
among
children
pathogen
detect
hbov
mrna
ci
strongli
associ
cap
conclus
detect
hbov
mrna
dna
associ
cap
support
pathogen
role
hbov
cap
hbov
mrna
could
use
target
diagnost
test
human
bocaviru
hbov
dna
viru
famili
parvovirida
first
identifi
nasopharyng
aspir
children
respiratori
tract
infect
rti
four
genotyp
recogn
hbov
type
detect
approxim
respiratori
tract
specimen
children
rti
hbov
type
detect
stool
respiratori
tract
specimen
patient
diarrhea
rti
diagnosi
hbov
infect
gener
reli
amplif
viral
genom
dna
routin
respiratori
tract
specimen
hbov
genom
dna
shed
continu
intermitt
month
follow
acut
infect
often
low
load
complic
epidemiolog
studi
publish
studi
provid
conflict
inform
potenti
associ
hbov
acut
pediatr
rti
sever
studi
report
associ
hbov
detect
acut
otiti
media
rti
includ
communityacquir
pneumonia
cap
especi
young
children
other
found
similar
detect
rate
control
importantli
studi
differenti
acut
infect
prolong
shed
recent
suggest
increas
hbov
load
respiratori
specimen
viremia
seroconvers
use
differenti
acut
infect
prolong
shed
addit
recent
studi
limit
number
children
rti
n
asymptomat
control
n
demonstr
splice
hbov
capsid
messeng
rna
mrna
measur
activ
viral
replic
strongli
associ
rti
particularli
lower
rti
detect
hbov
genom
dna
similarli
detect
mrna
use
marker
acut
infect
parvovirus
basi
find
hypothes
splice
viral
capsid
mrna
produc
activ
replic
may
better
marker
hbov
genom
dna
acut
rti
associ
hbov
infect
studi
test
hypothesi
perform
polymeras
chain
reaction
pcr
analysi
splice
capsid
mrna
genom
dna
nasopharyng
np
oropharyng
op
swab
specimen
children
hospit
cap
children
undergo
elect
outpati
surgeri
asymptomat
enrol
control
particip
enrol
center
diseas
control
prevent
cdc
etiolog
pneumonia
commun
epic
studi
larg
multicent
prospect
studi
patient
hospit
cap
includ
children
age
year
hospit
cap
enrol
cdc
epic
studi
primari
children
hospit
salt
lake
citi
utah
site
monro
carel
jr
children
hospit
vanderbilt
univers
nashvil
one
tennesse
site
memphi
tennesse
site
exclud
analysi
site
enrol
control
children
hospit
clinic
cap
ie
acut
infect
defin
feverchil
hypothermia
leukocytosi
leukopenia
combin
acut
respiratori
ill
radiograph
cap
base
detect
consolid
infiltr
pleural
effus
enrol
januari
june
children
undergo
elect
outpati
surgeri
enrol
control
februari
utah
site
march
nashvil
tennesse
site
hereaft
tennesse
site
june
detail
laboratori
clinic
inform
collect
per
epic
studi
protocol
supplementari
method
patient
control
caregiv
ask
provid
inform
consent
assent
appropri
studi
protocol
approv
institut
review
board
institut
cdc
control
exclud
fever
respiratori
symptom
day
enrol
receiv
live
attenu
influenza
vaccin
day
enrol
undergo
otolaryngolog
surgeri
time
enrol
viral
bacteri
respiratori
pathogen
sought
per
epic
studi
protocol
describ
previous
supplementari
method
specimen
refriger
upon
collect
within
mean
hour
collect
frozen
store
time
extract
februari
utah
site
septemb
tennesse
site
specimen
stabil
assess
describ
supplementari
method
hbov
capsid
mrna
splice
variant
assay
hbov
type
amplifi
use
primer
equimolar
mix
primer
probe
supplementari
tabl
total
nucleic
acid
quantitect
probe
revers
transcript
rt
pcr
kit
qiagen
figur
assay
describ
supplementari
method
analyt
sensit
quantit
result
calcul
use
vitrotranscrib
hbov
capsid
mrna
extern
standard
test
crossamplif
hbov
dna
specimen
utah
site
greatest
hbov
dna
load
rang
copiesml
test
hbov
transcript
without
revers
transcript
step
amplif
expect
without
revers
transcriptas
step
genom
dna
crossamplifi
hbov
genom
dna
amplifi
use
equimolar
mix
primer
capsid
mrna
transcript
assay
modifi
materi
publish
elsewher
capsid
mrna
detect
assay
span
differ
splice
site
altern
capsid
mrna
nucleotid
number
b
five
specimen
highest
viral
dna
load
utah
site
test
red
without
blue
revers
transcriptas
rt
use
capsid
mrna
detect
assay
minim
crossamplif
seen
specimen
highest
dna
load
level
fold
lower
dna
load
correspond
specimen
lower
rt
step
supplementari
tabl
total
nucleic
acid
custom
hot
start
pcr
master
mix
promega
detect
hbov
type
without
differenti
quantit
pcr
qpcr
perform
thermocycl
appli
biosystem
melt
analysi
perform
follow
amplif
specimen
melt
peak
consid
posit
test
result
extern
standard
curv
creat
use
serial
dilut
plasmid
use
determin
analyt
sensit
quantifi
hbov
genom
dna
copi
descript
statist
use
character
studi
cohort
categor
variabl
compar
use
test
fisher
exact
test
appropri
normal
distribut
continu
variabl
compar
use
test
nonnorm
distribut
continu
variabl
compar
use
wilcoxonmannwhitney
u
test
bivari
comparison
odd
ratio
or
exact
confid
interv
ci
calcul
adjust
or
aor
deriv
multivari
stepwis
logist
regress
model
use
p
valu
entri
exit
criterion
stratifi
analys
conduct
among
patient
posit
splice
capsid
hbov
mrna
posit
hbov
dna
neg
splice
capsid
mrna
neg
hbov
use
analysi
varianc
primari
stratifi
analys
includ
enrol
control
assess
potenti
bias
perform
number
sensit
analys
analysi
limit
control
develop
fever
respiratori
symptom
day
enrol
exclud
individu
incub
infect
supplementari
method
analysi
limit
patient
enrol
februarymarch
june
concurr
control
address
season
differ
analysi
limit
control
subsequ
symptom
enrol
seasonmatch
patient
analysi
limit
control
subsequ
symptom
seasonmatch
patient
respiratori
pathogen
detect
per
epic
studi
protocol
ie
hbov
monodetect
statist
comparison
perform
fashion
analys
conduct
use
stata
statacorp
colleg
station
tx
r
r
foundat
statist
comput
vienna
austria
specimen
avail
children
cap
control
utah
children
cap
control
tennesse
enrol
statist
demograph
inform
children
cap
control
shown
tabl
patient
control
site
gener
similar
supplementari
tabl
control
older
patient
median
age
year
interquartil
rang
iqr
year
vs
year
iqr
year
p
like
male
vs
p
overal
children
cap
control
underli
medic
condit
p
retest
store
rna
maximum
storag
durat
month
specimen
posit
respiratori
syncyti
viru
demonstr
specimen
stabil
supplementari
result
supplementari
tabl
hbov
genom
dna
reproduc
detect
copi
per
reaction
hbov
type
copi
per
reaction
hbov
type
wherea
hbov
capsid
mrna
reproduc
detect
copi
per
reaction
capsid
mrna
type
crossamplif
studi
identifi
lowlevel
amplif
specimen
greatest
hbov
dna
load
copiesml
specimen
nextgreatest
hbov
dna
load
figur
crossamplif
result
falseposit
capsid
mrna
level
lower
true
transcript
copi
number
revers
transcriptas
minim
crossamplif
genom
dna
specimen
greatest
hbov
dna
load
unlik
significantli
contribut
capsid
mrna
detect
children
cap
sever
peak
hbov
capsid
mrna
detect
marchjuli
octoberdecemb
mayaugust
supplementari
figur
hbov
dna
detect
yearround
peak
match
observ
capsid
mrna
supplementari
figur
overal
hbov
capsid
mrna
detect
children
cap
control
exact
ci
associ
hbov
capsid
mrna
detect
cap
figur
overal
hbov
preval
lower
tennesse
site
patient
control
utah
site
patient
control
supplementari
figur
sensit
analys
associ
hbov
cap
significantli
differ
entir
cohort
figur
associ
hbov
capsid
mrna
detect
cap
strongest
limit
particip
pathogen
detect
children
cap
control
ci
stratif
enrol
site
hbov
monodetect
significantli
associ
cap
utah
site
ci
reach
statist
signific
tennesse
site
multivari
logist
regress
adjust
age
enrol
month
detect
respiratori
virus
detect
hbov
capsid
mrna
remain
strongli
associ
cap
aor
ci
subanalys
site
aor
utah
tennesse
site
similar
despit
lower
preval
tennesse
site
supplementari
figur
overal
children
cap
control
posit
hbov
dna
ci
figur
hbov
dna
preval
lower
tennesse
site
patient
control
utah
site
patient
control
supplementari
figur
sensit
analys
associ
hbov
cap
significantli
differ
entir
cohort
figur
adjust
age
enrol
month
detect
respiratori
virus
detect
hbov
genom
dna
significantli
associ
cap
aor
ci
sitespecif
result
shown
supplementari
figur
among
children
detect
capsid
mrna
median
mrna
load
copiesml
children
cap
copiesml
control
p
mannwhitney
test
figur
among
children
detect
hbov
genom
dna
median
viral
load
higher
cap
copiesml
rang
copiesml
control
copiesml
rang
copiesml
p
addit
proport
children
high
hbov
dna
load
copiesml
greater
children
cap
control
figur
stratifi
capsid
mrna
statu
median
hbov
dna
load
order
magnitud
higher
capsid
mrnaposit
children
cap
copiesml
control
copiesml
capsid
mrnaneg
children
cap
copi
ml
control
copiesml
figur
compar
children
cap
hbov
capsid
mrna
posit
hbov
dna
posit
capsid
mrna
neg
without
evid
hbov
neither
capsid
mrna
dna
posit
tabl
capsid
mrnaposit
children
cap
younger
median
year
iqr
hbov
dnaposit
children
cap
median
year
iqr
year
p
hbovneg
patient
median
year
iqr
year
p
capsid
mrnaposit
children
cap
like
underli
condit
less
like
respiratori
pathogen
codetect
tabl
hbov
infect
preval
young
children
limit
analysi
children
age
year
n
children
cap
control
associ
hbov
cap
greater
detect
capsid
mrna
show
detect
hbov
capsid
mrna
strongli
associ
cap
aor
ci
asymptomat
concurr
analysi
limit
asymptomat
control
patient
enrol
januari
utah
patient
februari
tennesse
patient
concurr
analysi
limit
patient
enrol
januari
asymptomat
analysi
limit
control
confirm
remain
symptom
free
day
number
indic
size
group
given
differ
stratif
ci
confid
interv
odd
ratio
median
dna
load
approxim
higher
children
cap
copiesml
control
copiesml
differ
statist
signific
howev
subset
children
cap
well
control
hbov
dna
load
copiesml
c
stratifi
hbov
dna
load
hbov
capsid
mrna
posit
median
hbov
dna
load
higher
capsid
mrnaposit
children
cap
copiesml
control
copi
ml
capsid
mrnaneg
children
cap
copiesml
control
copiesml
convers
hbov
dna
load
similar
capsid
mrnaneg
patient
control
capsid
mrnaposit
patient
control
children
hbov
nucleic
acid
detect
shown
sensit
analys
even
though
hbov
preval
tennesse
site
approxim
lower
utah
site
strength
associ
hbov
cap
similar
site
consist
across
number
sensit
analys
contrast
detect
hbov
genom
dna
significantli
associ
cap
adjust
age
season
codetect
pathogen
high
hbov
dna
load
associ
cap
extens
overlap
viral
load
patient
control
contrast
hbov
dna
load
consist
higher
capsid
mrnaposit
children
capsid
mrnaneg
children
presenc
hbov
capsid
mrna
sign
activ
viral
replic
may
better
diagnost
target
hbov
dna
diagnosi
activ
infect
sinc
identif
decad
ago
etiolog
role
hbov
acut
rti
children
controversi
numer
patient
sever
fatal
pneumonia
describ
hbov
sole
pathogen
detect
howev
frequent
detect
asymptomat
children
common
codetect
respiratori
virus
led
question
regard
pathogen
role
studi
link
hbov
respiratori
diseas
critic
reli
crosssect
design
conveni
sampl
inadequ
control
group
fail
confid
exclud
altern
pathogen
caus
symptom
potenti
confound
includ
incomplet
match
age
sampl
method
time
yearseason
differ
protocol
test
respiratori
pathogen
select
control
increas
risk
hbov
infect
much
controversi
relat
difficulti
identifi
acut
hbov
infect
exclud
potenti
etiolog
hbov
shed
month
reactiv
upon
infect
pathogen
detect
genom
hbov
dna
alon
like
suitabl
identifi
acut
clinic
relev
infect
context
studi
weak
associ
hbov
dna
unadjust
analysi
cap
ci
attenu
adjust
analysi
aor
ci
consist
prior
literatur
demonstr
limit
viral
dna
target
detect
viremia
seroconvers
high
viral
load
propos
altern
approach
assess
impact
hbov
detect
method
limit
viremia
detect
acut
infect
studi
wide
studi
seroconvers
defin
immunoglobulin
posit
increas
immunoglobulin
g
igg
titer
increas
igg
avid
identifi
acut
infect
requir
serial
collect
blood
specimen
limit
clinic
util
high
hbov
load
upper
respiratori
tract
specimen
associ
acut
infect
moresever
diseas
threshold
propos
eg
copiesml
howev
viral
load
patient
highli
variabl
overlap
significantli
control
limit
use
approach
addit
defin
threshold
difficult
even
homogen
specimen
plasma
serum
viral
load
differ
test
method
requir
complex
standard
surpris
viral
load
determin
led
inconsist
result
nonhomogen
specimen
respiratori
secret
recent
longitudin
studi
martin
et
al
demonstr
incid
infect
defin
infect
involv
primari
shed
hbov
dna
associ
respiratori
symptom
infant
suggest
hbov
true
pathogen
small
studi
christensen
et
al
detect
hbov
capsid
mrna
respiratori
tract
hbov
dnaposit
children
rti
hbov
dnaposit
asymptomat
children
suggest
capsid
mrna
may
marker
acut
symptomat
infect
serial
test
singl
patient
demonstr
viral
capsid
mrna
detect
acut
infect
ie
within
day
onset
symptom
hbov
genom
dna
persist
addit
period
approxim
week
studi
parvovirus
ie
human
parvoviru
canin
parvoviru
type
also
indic
capsid
mrna
detect
might
marker
incid
infect
result
support
notion
demonstr
strong
associ
hbov
capsid
mrna
cap
especi
children
test
neg
larg
batteri
respiratori
pathogen
contrast
earlier
studi
hbov
capsid
mrna
present
studi
much
larger
includ
parallel
test
hbov
dna
capsid
mrna
use
combin
nasopharyng
oropharyng
swab
specimen
present
studi
patient
radiograph
confirm
cap
control
survey
develop
respiratori
symptom
week
follow
specimen
collect
consist
acut
infect
detect
hbov
capsid
mrna
also
correl
higher
viral
dna
load
present
previou
studi
figur
taken
togeth
larg
prospect
multicent
case
control
studi
expand
previou
studi
confirm
stronger
associ
hbov
capsid
mrna
detect
hbov
genom
dna
detect
cap
detect
viral
capsid
mrna
offer
sever
advantag
test
diagnos
recent
hbov
infect
perform
upper
respiratori
tract
specimen
without
need
viral
load
measur
addit
absenc
standard
serolog
test
rtpcr
detect
hbov
capsid
mrna
easili
implement
epidemiolog
studi
strength
present
studi
includ
larg
size
multisit
design
strict
definit
pneumonia
thorough
search
respiratori
pathogen
use
sensit
comprehens
method
therefor
altern
etiolog
could
exclud
confid
use
specimen
data
larg
prospect
multicent
studi
children
hospit
radiograph
confirm
cap
control
conduct
adjust
sensit
analys
studi
reduc
methodolog
limit
compromis
previou
studi
remain
limit
includ
potenti
crossdetect
dna
hbov
capsid
mrna
assay
address
design
rtpcr
assay
hbov
capsid
mrna
assay
span
splice
site
remov
approxim
kb
hbov
rna
result
crossdetect
hbov
dna
almost
elimin
figur
perform
hbov
capsid
mrna
detect
test
could
improv
elimin
crossdetect
viral
dna
optim
analyt
clinic
sensit
although
use
multisit
design
control
avail
epic
studi
site
enrol
entir
studi
period
perform
sensit
analys
demonstr
limit
bia
result
control
older
children
cap
adjust
analysi
futur
studi
agematch
control
help
reduc
potenti
confound
effect
age
children
enrol
epic
studi
period
studi
cover
respiratori
season
despit
size
epic
studi
detect
patient
hbov
mrna
preval
potenti
lead
smallsamples
bia
comparison
preval
respiratori
virus
epic
respiratori
syncyti
viru
rhinoviru
metapneumoviru
adenoviru
parainfluenza
viru
influenza
viru
coronaviru
last
potenti
unmeasur
confound
futur
studi
across
addit
geograph
region
respiratori
season
requir
confirm
result
summari
result
provid
evid
hbov
strongli
associ
cap
result
correl
hbov
capsid
mrna
detect
cap
highli
consist
geograph
independ
climat
divers
locat
across
unit
state
approxim
differ
overal
hbov
preval
addit
strengthen
associ
detect
hbov
replic
cap
result
suggest
detect
viral
replic
rtpcr
might
provid
better
target
diagnos
primari
hbov
diseas
tool
studi
etiolog
role
hbov
supplementari
materi
avail
journal
infecti
diseas
onlin
consist
data
provid
author
benefit
reader
post
materi
copyedit
sole
respons
author
question
comment
address
correspond
author
